(11bS)-4-Hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide

Catalog No.: 
ACPMWV481
CAS No.: 
35193-64-7
Molecular Formula: 
C20H13O4P
Molecular Weight: 
348.29
(11bS)-4-Hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%
100g97%
500g97%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(11bS)-4-Hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide
IUPAC Name4-hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide
MDL No.MFCD00010045
Molecular FormulaC20H13O4P
Molecular Weight348.29
SMILESOP1(OC2=CC=C3C=CC=CC3=C2C4=C5C=CC=CC5=CC=C4O1)=O
InChI KeyJEHUZVBIUCAMRZ-UHFFFAOYSA-N
Synonym(R)-(-)-1,1'-Binaphthyl-2,2'-diyl hydrogenphosphate, >=98% | (S)-(+)-2,2'-Dihydroxy-1,1'-binaphthyl Hydrogen Phosphate | Dinaphtho[2,1-d:1,2-f][1,3,2]dioxaphosphepin-4-ol 4-oxide # | FT-0604445 | J-019988 | AC-26903 | B1144 | EINECS 252-425-8 | AC7768 | (
CAS No.35193-64-7
PubChem CID99589

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACPMWV481 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPMWV481 route product structure diagram
    ACPMWV48135193-64-7In Stock
Inquiry

2. ACPMWV481 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPMWV481 route product structure diagram
    ACPMWV48135193-64-7In Stock
Inquiry

3. ACPMWV481 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPMWV481 route product structure diagram
    ACPMWV48135193-64-7In Stock
Inquiry

Comments (0)